Jade Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2024-09-30 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -1 | -218 |
EBITDA | -32,133 | -16,019 |
EBIT | -32,134 | -16,237 |
Net Income | -32,134 | -16,867 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -36,671 | -6,802 |
Cash | 220,942 | 87,970 |
Basic Shares | 28,431 | 824 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Gross Profit | -282 | -96 | -68 | -15 |
EBITDA | -75,369 | -51,418 | -22,945 | |
EBIT | -75,465 | -51,486 | -22,960 | |
Net Income | -93 | -75,521 | -51,511 | -22,963 |
Free Cash Flow | -45 | -56,920 | -39,317 | -27,580 |
Cash | 33,751 | 23,491 | 22,397 | 54,197 |
Basic Shares | 5 | 752 | 699 | 697 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.86 |
2025-03-31 | -$12.10 |
2024-12-31 | -$6.55 |
2024-09-30 | -$19.68 |
